(Q2459042)

English

ipilimumab

pharmaceutical drug

MDX-010
MDX-101
MOAB-CTLA-4
MDX-CTLA-4

In more languages

Statements

type of chemical entity

0 references

chemical compound

0 references

1 reference

Ipilimumab (English)

language of work or name

publication date

17 November 2015

image of molecular model or crystal lattice model

Ipilimumab 5TRU.png
2,048 × 1,767; 152 KB

space-filling model

0 references

active ingredient in

1 reference

European Medicines Agency product number

EMEA/H/C/002213

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002213/human_med_001465.jsp

22 March 2017

World Health Organisation international non-proprietary name

ipilimumab (English)

1 reference

language of work or name

Ipilimumab (English)

19 January 2016

medical condition treated

metastatic melanoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

renal cell carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

myelodysplastic syndrome

1 reference

Drug Indications Extracted from FAERS

2 October 2018

non-small-cell lung carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

physically interacts with

cytotoxic T-lymphocyte associated protein 4

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL1789844

route of administration

intravenous infusion and defusion

0 references

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category A

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Ipilimumab

16 February 2018

has characteristic

biopharmaceutical

1 reference

Ipilimumab (English)

language of work or name

publication date

17 November 2015

subject has role

monoclonal antibody

1 reference

language of work or name

Ipilimumab (English)

publication date

17 November 2015

Identifiers

CAS Registry Number

1 reference

language of work or name

Ipilimumab (English)

publication date

17 November 2015

1 reference

language of work or name

Ipilimumab (English)

19 January 2016

0 references

1 reference

language of work or name

Ipilimumab (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

0 references

MeSH descriptor ID

subject named as

Ipilimumab

0 references

D12.776.124.486.485.114.224.060.798

0 references

D12.776.124.790.651.114.224.060.798

0 references

D12.776.377.715.548.114.224.200.798

0 references

1 reference

26 February 2018

0 references

1 reference

language of work or name

IPILIMUMAB (English)

19 January 2016

MedlinePlus drug identifier

0 references

1 reference

language of work or name

IPILIMUMAB (English)

19 January 2016

1 reference

language of work or name

Ipilimumab (English)

19 January 2016

0 references

Encyclopædia Britannica Online ID

science/ipilimumab

subject named as

ipilimumab

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q2459042&oldid=2190020011"